Abstract. Adrenal neuroblastoma and pheochromocytoma have the same embryonic origin from neural crest cells and mainly arise from the adrenal medulla. Recently, transgenic mice exhibiting tumors in the bilateral adrenal medulla by the expression of SV40 T-antigen were developed. In this study, we investigated mRNA expression in adrenal tumors of transgenic mice and compared them with human pheochromocytoma by DNA microarray analysis. To compare mouse adrenal tumors and human pheochromacytoma, we found that the expressions of noradrenergic neuron-related genes, including dopa decarboxylase, phenylethanolamine-N-methyltransferase and chromogranin B, were up-regulated in humans but not in mice; however, the expression of neuroblastoma-related genes, including Mycn, paired-like homeobox 2b, Á-aminobutyric acid A receptor ß3 subunit, islet 1 and kinesin family member 1A, was up-regulated in both species. From the gene expression profiles, the characterization of mouse adrenal tumor, may be similar to that of human adrenal neuroblastoma rather than pheochromacytomas. This mouse model would be a useful tool for the development of anticancer drugs and for understanding the etiology of adrenal neuroblastoma.
Introduction
Adrenal neuroblastoma and pheochromocytoma have the same embryonic origin from neural crest cells and mainly arise from the adrenal medulla. Adrenal neuroblastoma is the most common and deadly extracranial solid childhood tumor, exhibiting marked variation in clinical presentation, ranging from localized to high metastatic disease. Neuroblastoma causes 15% of cancer-related deaths in children (1) . Patients with early-stage neuroblastoma, particularly those detected by a mass screening program, are known to have a good prognosis, and the tumors of these patients possess the ability to differentiate and regress spontaneously (2) . In contrast, patients with advanced-stage neuroblastoma still have a poor prognosis despite recent developments in treatment (1) . Pheochromocytomas are catecholamine-producing tumors that occur from chromaffin cells of adrenal medulla or extra-adrenal location, leading to paroxysmal or persistent hyper-tension in most patients (3, 4) . Pheochromocytoma generally occurs as a benign tumor, but 10-25% of cases are malignant at first surgery or at recurrence, with metastasis development in the lymph nodes, bone, liver or lung. Once pheochromocytoma has metastasized, there is no curative therapy; therefore, the availability of reliable tumor models for adrenal neuroblastoma and pheochromocytoma to test novel chemotherapeutic agents remains an important aspect to improve survival.
For the development of new therapeutic drugs for tumors of the adrenal medulla, in vivo rodent models are useful in addition to in vitro cultured tumor cells. In the early 1990s, adrenal medullary neoplasms were reported in transgenic mice carrying simian virus 40 (SV40) or polyoma viral T-antigens driven by a variety of promoters (5) (6) (7) (8) , including those for tyrosine hydroxylase (Th) (8) and phenylethanolamine Nmethyltransferase (Pnmt) (6) . Some were classified as primitive neuroectodermal tumors (9) or neuroblastoma (5) . Better differentiated pheochromocytomas and hyperplastic nodules have subsequently been reported to occur with high frequency in transgenic mice expressing c-mos (10, 11) or multiple endocrine neoplasia (MEN) 2B-type mutant rearranged during transfection (RET) (Met 918) (12) and in retinoblastoma (Rb) (13) , phosphatase and tensin homolog deleted from chromosome (Pten) (14) or neurofibromatosis 1 (Nf1) (15) knockout mice. Unfortunately, some of these mice have not been maintained and may be permanently lost as experimental models.
Recently, we developed transgenic mice exhibiting tumors in the bilateral adrenal glands by the expression of SV40 T-antigen and have maintained them as a experimental model (16) . Genome-wide gene expression studies will provide insight into the genes and molecular pathways that govern the pathogenesis of adrenal tumors; however, this has not been reported in adrenal tumor model mice. In this study, we investigated mRNA expression in adrenal tumors of transgenic mice and compared them with human pheochromocytoma by DNA microarray analysis.
Materials and methods
Animals. Transgenic mice carrying tetracycline inducible SV40 T-antigen, a fusion gene comprising tetracycline-responsive elements (TRE) with cytomegarovirus promoter and SV40 T-antigen were generated by microinjection of fertilized C57/B6 mouse eggs as previously reported (16) . Transgenic mice were used as heterozygotes. Animal experiments were conducted with ethics approval from our institutional animal care and use committee.
Histopathology. Excised adrenal tumors from transgenic mice at the age of 5, 9, 13, 15, 17 and 21 weeks (5T, 9T, 13T, 15T, 17T and 21T, respectively) and normal adrenal gland from non-transgenic littermates at the age of 5, 9, 13 and 17 weeks (5N, 9N, 13N and 17N , respectively) were immediately frozen, sectioned 20-μm thick and mounted. The sections were stained with hematoxylin and pure eosin (H&E staining) (Muto Pure Chemicals Co., Ltd., Tokyo, Japan) for histopathological examination.
Tumor procurement. Human tumor specimens were collected from patients who underwent surgery at Kyoto University Hospital (Kyoto, Japan). Specimens were procured under Institutional Review Board-approved protocols compliant with international guidelines and with informed consent from patients. Tumor samples and normal adjacent samples were frozen and stored at -80˚C shortly after surgical resection. Total RNA was extracted from tumors using an RNeasy Midi Kit (Qiagen, Hilden, Germany). The quality and quantity of RNA were sufficient for gene expression profiling in 7 pheochromocytoma and 2 normal adjacent adrenal medulla from 2 patients with pheochromocytoma.
RT-PCR analysis. Total RNA was isolated from mouse adrenal tumors using the RNeasy Midi Kit (Qiagen). RNA yield and purity were checked by spectrometric measurements at 260 and 280 nm, and RNA electrophoresis, respectively. RT-PCR amplification was carried out as previously reported (17) . The profile of PCR amplification consisted of denaturation at 94˚C for 0.5 min, primer annealing at 55˚C for 0.5 min, and elongation at 72˚C for 0.5 min for 30 cycles. For the amplification of SV40 T-antigen cDNA, the primers SV40 T-antigen-FW, 5'-AAACACTGCAGGCCAGATTT-3', and SV40 T-antigen-RW, 5'-AAATGAGCCTTGGGACTGTG-3', were used. For the amplification of mouse ß-actin cDNA, the primers ß-actin-FW, 5'-TGTGATGGTGGGAATGGGT CAG-3', and ß-actin-RW, 5'-TTTGATGTCACGCACGATT TCC-3', were used. PCR products were analyzed by 1.5% agarose gel electrophoresis in a Tris-borate-EDTA (TBE) buffer. The products were visualized by ethidium bromide staining.
Real-time RT-PCR was performed on the corresponding cDNA synthesized from each sample described above. The optimized settings were transferred to the real-time PCR protocol with the iCycler MyiQ detection system (Bio-Rad Laboratories, Hercules, CA, USA) and SYBR Green I assay (iQ™ SYBER Green Supermix, Bio-Rad Laboratories) was used for quantification. Samples were run in triplicate and the expression level of each mRNA was normalized for the amount of ß-actin in the same sample. Difference of 1 cycle was calculated as a 2-fold-change in the gene expression.
DNA microarray. For DNA microarray experiments, 0.5 μg aliquots of total RNA from 13N, 13T, 15T, 17T and human tumor specimens were labeled using the Quick Amp Labeling Kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's instructions. After purification of Cy3-labeled cRNA with RNeasy mini spin columns (Qiagen), 1.65 μg aliquots of Cy3-labeled cRNA were hybridized to Whole Mouse genome Oligo Microarray 44K x 4 (Agilent Technologies) or Whole Human genome Oligo Microarray 44K x 4 (Agilent Technologies) using the manufacturer's hybridization protocol. After the washing step, the microarray slides were analyzed with an Agilent Technologies Microarray scanner.
For further analysis, the data were imported into the GeneSpring ® 10 Software (Agilent Technologies) and normalized by median centering of arrays and genes. In mouse adrenal tumors, all transcripts showed a minimum change in the expression level of at least 10-fold compared with the adrenal gland of normal mice. In a comparison of the expression profiles between mouse and human adrenal tumors, hierarchical clustering of the above identified genes in mouse adrenal tumor and image plots using available human orthologues in pheochromocytoma were displayed with gene ordering based on hierarchical clustering of the mouse data set.
Results
Tumor appearance and SV40 T-antigen expression. We previously reported that the ectopic expression of SV40 T-antigen in adrenal medulla developed bilateral adrenal tumors at 12-13 weeks of age in mice (16) . In hematoxylin and eosin-stained sections of adrenal glands, mild hyperplasia in the adrenal medulla of transgenic mice was already observed at 5 and 9 weeks of age (Fig. 1A , B, E and F). Subsequently, transgenic mice, beginning at 13 weeks of the age, developed carcinoma of the adrenal gland (Figs. 1I, J and 2A), and by 15 weeks of age, most adrenal tumors were between 0.5 and 1.0 cm in diameter ( Fig. 2A) . At 17 weeks of the age, tumors of the adrenal glands had enlarged to 1.0-1.5 cm diameter, and at 21 weeks of age, to 1.5-2.0 cm. The tumors in 17T were composed of undifferentiated cells with a large nucleus ( Fig. 1M and N) compared with adrenal glands in non-transgenic mice.
Next, we confirmed the expression levels of SV40 Tantigen mRNA in the developing tumors of transgenic mice. Expression levels of SV40 T-antigen from 5T to 17T were similar, but those in 5N and 13N were not detected (Fig. 2B ), suggesting that SV40 T-antigen was expressed in adrenal glands of transgenic mice at an early age and induced adrenal hyperplasia.
Comparison of gene expression patterns between mouse adrenal tumor and human pheochromocytoma. Cells of adrenal neuroblastomas have neuroblastic morphology and do not express the adrenal chromaffin marker Pmnt, but they share phenotypic characteristics with immature sympathetic neuroblasts present as nests of cells in the developing adrenal gland (18) . Although sympathetic neurons and chromaffin cells are developmentally related and functionally similar, a defining functional difference between the two cell types is that only chromaffin cells express Pmnt (18) .
We compared the expression profile of transgenic mice with that of human pheochromocytoma by DNA microarray (Fig. 3) . To investigate mRNA expression in developing adrenal tumors of transgenic mice, we used RNA of adrenal tumors from 13T, 15T and 17T, and of the normal adrenal gland from 13N as a control. Overall, the expression patterns of up-and down-regulated genes in both human benign and malignant pheochromocytomas were similar with those in mouse adrenal tumors (Fig. 3) . Furthermore, the expression profile in benign pheochromocytomas was very similar to that in malignant pheochromocytomas, therefore, in subsequent analysis, we used average of four benign and three malignant pheochromocytomas for comparison of expression level with mouse adrenal tumors. In adrenal tumors of transgenic mice, Pmnt expression was absent and other noradrenergic synthesisrelated genes also greatly reduced compared with in normal adrenal gland, although up-regulated in human pheochromacytoma (Table I) . It has been reported that Pmnt expression was absent or greatly reduced in tumors associated with viral T-antigens (8, 19) . Furthermore, no difference in blood pressure between transgenic and non-transgenic mice was observed (~60 mmHg in mean blood pressure) (data not shown). These findings indicated that the characteristics of human pheochromocytoma regarding noradrenergic secretion and hypertension were dissimilar to those of mouse adrenal tumors.
Recently, Cheung et al have reported that cyclin D1 (CCND1), dopa decarboxylase (DDC), Á-aminobutyric acid A receptor ß3 subunit (GABRB3), islet 1 (ISL1), kinesin family member 1A (KIF1A), and paired-like homeobox 2b (PHOX2B) were abundantly expressed in stage IV human neuroblastoma tumors and these expressions were useful in predicting patient outcome (20) . In both mouse and human adrenal tumors, Phox2b, Gabrb3, Isl1 and Kif1a were also up-regulated (Table I) . Furthermore, we found 49 up-regulated genes and 66 down-regulated genes which were >10-fold different between a normal adrenal gland and the adrenal tumor in both mice and humans (Tables II and III) . Among them, we found that the expressions of doublecortin and CaM kinaselike 1 (Dclk1), dihydropyrimidinase-like 3 (Dpysl3), embryonic lethal, abnormal vision, Drosophila-like 3 (Elavl3), GATA binding protein 2 (Gata2), GATA binding protein 3 (Gata3), hairy/enhancer-of-split related with YRPW motif 1 (Hay1), myelin transcription factor 1-like (Myt1l), transgelin 3 (Tagln3), and transcription factor AP-2 ß (Tcfap2b), which are related to nervous system development, were strongly upregulated in both human and mouse adrenal tumors (Table II) , and the expression of many genes related to lipid metabolic Figure 3 . Gene expression patterns of mouse adrenal tumor-specific signature in human pheochromocytoma. Hierarchical clustering of mouse adrenal tumors (13T, 15T and 17T)-specific genes (~2,500 genes), which were >10-fold higher and lower than in the normal adrenal gland (13N), and image plots using available human orthologues in pheochromocytoma are shown with gene ordering based on hierarchical clustering of the mouse data set. Expression profiles in four benign pheochromocytomas (Pheo), three malignant pheochromocytomas (Mal Pheo) and two normal adjacent adrenal medulla (normal) were aligned beside those in mouse tumors. Genes with a relatively higher level of expression are shown in red and those with a lower level of expression in green.
process and electron transport was strongly down-regulated (Table III) . The reasons for suppression of the metabolism might be that energy (ATP) in tumor cells is mainly or only provided by glycolysis in the cytoplasm and suppresses oxidative phosphorylation in mitochondria (Warburg effect) (21) .
We also found that G protein-regulated inducer of neurite outgrowth 1 (Grin1) (22) , insulin-like growth factor 2 gene (Igf2) (23) , embryonic lethal, abnormal vision, Drosophilalike 4 (Elavl4) (24) , and cadherin-like 22 (Cdh22) (25) , which are known to relate with neuroblastoma progression, were strongly up-regulated in both mouse and human adrenal tumors (Table II) . These identified genes might be important for the development of adrenal tumors in mice and humans. From gene expression profiles, the characterization of mouse adrenal tumor might be similar to that of human adrenal neuroblastoma rather than pheochromacytoma.
Discussion
In this study, we investigated mRNA expression in adrenal tumors of transgenic mice carrying SV40 T-antigen by DNA microarray analysis. The SV40 T-antigen oncoprotein binds to and functionally inactivates two major tumor suppressor genes, Rb and p53, which are often involved in many human tumors, and strongly affects many genes associated with DNA replication, damage repair, cytokinesis, and chromosome maintenance. It has been reported that proliferative gene expression patterns driven by the SV40 T-antigen were shared by transgenic mice carrying SV40 T-antigen, which Table I . Adrenal gland-related genes in human pheochromocytoma and mouse adrenal tumors as shown by cDNA microarray. 
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Pheo, human pheochromocytoma; normal, human normal adrenal medulla. Table II . The highly up-regulated (>10-fold) genes both in human pheochromocytoma and mouse adrenal tumor (17T) as shown by cDNA microarray.
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Description 13T/13N 15T/13N 17T/13N Pheo/ Biological process symbol normal  --------------------------------------------------------------------------------------------------- (26) . Therefore, we compared the expression profiles of the SV40 T-antigen signature between adrenal tumors and three tumor types of transgenic mice carrying SV40 T-antigen, and the expression profile of mouse adrenal tumor was very similar to other tumor types of transgenic mouse (data not shown).
The SV40 T-antigen gene signature was not a feature of tumors initiated by other oncogenes or inactivation of suppressor genes but is most specific to tumors induced by T-antigen (26) . Transgenic overexpression of myc, ras, HER-2/neu, and polyoma viral middle T-antigen (PyMT) oncogenes driven by mouse mammary tumor virus (MMTV) promoter were most dissimilar to those of SV40 T-antigen in gene expression profiles; however, SV40 T-antigen viral oncoprotein can cause an intrinsic gene expression profile that recapitulates the aggressive phenotypes of aggressive Table II . Continued.
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Fructose (26) . In hematoxylin and eosin-stained sections, mouse adrenal tumor was composed of undifferentiated cells with a large nucleus (Fig. 1M and N) . From comparison of the gene expression profiles by hierarchical clustering, up-or down-regulated genes in mouse adrenal tumor were overall similar to those in human pheochromocytoma (Fig. 3) , but the expression patterns of noradrenergic neuron-related genes in mouse adrenal tumor were dissimilar with those in human pheochromocytoma ( Table I ), indicating that the characterization of mouse adrenal tumor was similar to that of human adrenal neuroblastoma rather than pheochromacytoma. This transgenic mouse might be a useful model of undifferentiated and aggressive adrenal neuroblastoma.
Researchers are studying chemotherapy drugs in order to find an effective therapy for neuroblastoma. In chemotherapy for high-risk neuroblastoma, the following drugs are often used: cyclophosphamide, ifosfamide, cisplatin, carboplatin, vincristine, doxorubicin (DXR), melphalan, etoposide (VP-16), teniposide (VM-26), and topotecan. In this study, we found that the expression of DNA topoisomerase II (Topo II·) mRNA in adrenal tumors of transgenic mice increased 120-150-fold compared to non-transgenic mice (data not shown); therefore, we investigated the antitumor effect for transgenic mice by DXR, which is an inhibitor of Topo II·. As a result, i.v. administration of DXR could suppress tumor growth significantly (data not shown), corresponding with the prognostic results from DNA array; therefore, this mouse model would be a useful tool for the development of anticancer drugs of neuroblastoma. Table III. Continued. 
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Pheo, human pheochromocytoma; normal, human normal adrenal medulla.
